Validation of a questionnaire for cognitive decline in German

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate the Subjective Cognitive Decline Questionnaire (SCD-Q) in the German language for patients undergoing dementia diagnostics. The SCD-Q is a screening tool that assesses self-perceived cognitive decline and includes both self-reported and informant-rated versions. The study will also explore the relationship between the SCD-Q results and various biomarkers associated with Alzheimer's disease, as well as cognitive tests. Follow-up visits will be conducted to gather comprehensive data on cognitive changes over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
* Provision of signed, written and dated informed consent
* Capacity to give informed consent

Exclusion Criteria:

* dementia in a very advance stage
* Illiteracy

Where it's running

• Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
  München, Bavaria, Germany Recruiting

Study contacts

• Principal investigator: Robert Perneczky, Prof. Dr. — Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
• Study coordinator: Carolin Kurz, Dr.
• Email: Psy.Alzheimerzentrum@med.uni-muenchen.de
• Phone: +4989440055863

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Effects of social isolation and interaction on dementia risk in people with subjective cognitive decline

  This study is trying to see how being socially isolated or interacting with others affects the risk of dementia in people who notice early signs of memory problems.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, China, Jiangsu · NCT06335836

• Using deep brain stimulation and cognitive training to improve memory in older adults with cognitive decline

  This study is testing whether a combination of brain stimulation and memory training can help older adults with early signs of memory problems improve their thinking skills.

  Recruiting Rotman Research Institute at Baycrest · Toronto, Ontario · NCT06095063

• Understanding cognitive decline and mild cognitive impairment in Alzheimer's disease

  This study looks at how people with different levels of memory issues, including those with Alzheimer's, feel about their cognitive decline to better understand how it progresses.

  Recruiting Barcelonabeta Brain Research Center, Pasqual Maragall Foundation · Barcelona, Catalonia · NCT03851523

• Blood biomarker cohort for memory disorders in older adults

  This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.

  Recruiting Yonsei University · Seoul, Seodamun-gu · NCT07880275

• Tau changes after hip or knee replacement surgery

  Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.

  Recruiting Uppsala University Hospital · Uppsala · NCT07871487

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.